Position in ALNY
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$9,751,400
-$2,111,294 QoQ
Shares Held
29,472
-1.2% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CIBC Asset Management Inc holds $117,481,189 across 42 Biotechnology names. ALNY ranks #3 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
106,893 | $47,732,000 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,517 | $32,850,334 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
29,472 | $9,751,400 | |
| 4 | INSM |
INSMED Inc
|
48,193 | $7,880,519 | |
| 5 | INCY |
Incyte Corp
|
42,643 | $4,013,559 | |
| 6 | MRNA |
Moderna, Inc.
|
78,526 | $3,989,120 | |
| 7 | TECH |
BIO-TECHNE Corp
|
34,856 | $1,821,574 | |
| 8 | RPRX |
Royalty Pharma plc
|
30,224 | $1,449,845 |
All Filings in ALNY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,751,400 | 29,472 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $11,862,694 | 29,832 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,507,088 | 5,498 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,779,799 | 5,458 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,464,048 | 5,422 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,208,081 | 5,134 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $1,232,959 | 4,483 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,032,507 | 4,249 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $601,087 | 4,022 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $768,319 | 4,014 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $765,426 | 4,322 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $796,608 | 4,194 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $839,541 | 4,191 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $976,028 | 4,107 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,062,048 | 5,306 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $771,838 | 5,292 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $879,643 | 5,387 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $908,779 | 5,359 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $902,134 | 4,778 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $737,581 | 4,351 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $612,764 | 4,340 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $543,144 | 4,179 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $608,462 | 4,179 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $603,696 | 4,076 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $443,672 | 4,076 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||